ALCAM and neoplasm: In SW480 and DLD-1 cells, the combination of niclosamide and metformin yielded a significant decrease of tumor spheres and a lower proportion of CD44+/CD166+ cells compared to those of cells treated with niclosamide or metformin alone (Figure 5A,C and Figure S5).